VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_19-vv-01262
Package ID: USCOURTS-cofc-1_19-vv-01262
Petitioner: Michael Postlewait
Filed: 2021-02-05
Decided: 2021-07-12
Vaccine: influenza
Vaccination date: 2018-09-16
Condition: Shoulder Injury Related to Vaccine Administration (SIRVA)
Outcome: compensated
Award amount USD: 72500

AI-assisted case summary:
Michael Postlewait filed a petition for compensation under the National Vaccine Injury Compensation Program on August 22, 2019, alleging he suffered a Shoulder Injury Related to Vaccine Administration (SIRVA) after receiving an influenza vaccine on September 16, 2018. He alleged that he received the vaccination in the United States, suffered residual effects for more than six months, and had not filed a civil action or received other compensation for his injury. The case was assigned to the Special Processing Unit. On February 4, 2021, the respondent filed a Rule 4(c) report conceding that Mr. Postlewait met the criteria for a Table SIRVA and was entitled to compensation. Chief Special Master Brian H. Corcoran issued a Ruling on Entitlement on February 5, 2021, finding Mr. Postlewait entitled to compensation based on the respondent's concession and the evidence of record. Subsequently, on May 27, 2021, the respondent filed a Proffer on Award of Compensation, recommending an award of $72,500.00 for pain and suffering, to which Mr. Postlewait agreed. Chief Special Master Corcoran issued a Decision Awarding Damages on July 12, 2021, awarding Mr. Postlewait a lump sum payment of $72,500.00 for pain and suffering, representing compensation for all damages available under Section 15(a). The award was to be paid via a check to Mr. Postlewait. Petitioner was represented by Paul R. Brazil of Muller Brazil, LLP, and respondent was represented by Julia Marter Collison of the U.S. Department of Justice. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of injury.

Theory of causation field:
Petitioner Michael Postlewait alleged a Shoulder Injury Related to Vaccine Administration (SIRVA) following an influenza vaccine administered on September 16, 2018. The respondent conceded that the injury met the criteria for a Table SIRVA. The case was decided based on this concession, and no specific medical experts or detailed causation theories beyond the Table designation were presented in the public text. Chief Special Master Brian H. Corcoran ruled on entitlement on February 5, 2021, and awarded $72,500.00 for pain and suffering on July 12, 2021, as a lump sum payment to the petitioner. Petitioner was represented by Paul R. Brazil, and respondent by Julia Marter Collison.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_19-vv-01262-0
Date issued/filed: 2021-03-09
Pages: 2
Docket text: PUBLIC ORDER/RULING (Originally filed: 02/05/2021) regarding 17 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:19-vv-01262-UNJ Document 19 Filed 03/09/21 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 19-1262V
UNPUBLISHED
MICHAEL POSTLEWAIT, Chief Special Master Corcoran
Petitioner, Filed: February 5, 2021
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Ruling on Entitlement; Concession;
HUMAN SERVICES, Table Injury; Influenza (Flu) Vaccine;
Shoulder Injury Related to Vaccine
Respondent. Administration (SIRVA)
Paul R. Brazil, Muller Brazil, LLP, Dresher, PA, for petitioner.
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for respondent.
RULING ON ENTITLEMENT1
On August 22, 2019, Michael Postlewait filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine
administration (“SIRVA”) after receiving an influenza vaccine on September 16, 2018.
Petition at 1, ¶ 2. Petitioner further alleges that he received the vaccination in the United
States, that he suffered the residual effects of his injury for more than six months, and
that neither he nor any other party has filed a civil action or received compensation for his
SIRVA. Id. at 1, ¶¶ 2, 11-12. The case was assigned to the Special Processing Unit of
the Office of Special Masters.
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means the ruling will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:19-vv-01262-UNJ Document 19 Filed 03/09/21 Page 2 of 2
On February 4, 2021, Respondent filed his Rule 4(c) report in which he concedes
that Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at
1. Specifically, Respondent agrees that Petitioner has satisfied the criteria for a Table
SIRVA. Id. at 3-4.
In view of Respondent’s position and the evidence of record, I find that
Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
2

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_19-vv-01262-1
Date issued/filed: 2021-07-12
Pages: 4
Docket text: PUBLIC DECISION (Originally filed: 05/27/2021) regarding 24 DECISION Stipulation/Proffer, Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:19-vv-01262-UNJ Document 30 Filed 07/12/21 Page 1 of 4
CORRECTED
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 19-1262V
UNPUBLISHED
MICHAEL POSTLEWAIT, Chief Special Master Corcoran
Petitioner, Filed: May 27, 2021
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Damages Decision Based on Proffer;
HUMAN SERVICES, Influenza (Flu) Vaccine; Shoulder
Injury Related to Vaccine
Respondent. Administration (SIRVA)
Paul R. Brazil, Muller Brazil, LLP, Dresher, PA, for Petitioner.
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On August 22, 2019, Michael Postlewait filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine
administration (“SIRVA”) after receiving an influenza vaccine on September 16, 2018.
Petition at 1, ¶ 2. The case was assigned to the Special Processing Unit of the Office of
Special Masters.
On February 5, 2021, a ruling on entitlement was issued, finding Petitioner entitled
to compensation for his SIRVA. ECF No. 17. On May 27, 2021, Respondent filed a proffer
on award of compensation (“Proffer”) indicating Petitioner should be awarded $72,500.00,
representing compensation for his pain and suffering. Proffer at 1, ECF No. 23. In the
Proffer, Respondent represented that Petitioner agrees with the proffered award. Id.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the decision will be available to anyone with access to the
internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact
medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.
If, upon review, I agree that the identified material fits within this definition, I will redact such material from
public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:19-vv-01262-UNJ Document 30 Filed 07/12/21 Page 2 of 4
Based on the record as a whole, I find that Petitioner is entitled to an award as stated in
the Proffer.
Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump
sum payment of $72,500.00, representing compensation for his pain and suffering,
in the form of a check payable to Petitioner. This amount represents compensation for
all damages that would be available under Section 15(a).
The clerk of the court is directed to enter judgment in accordance with this
decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:19-vv-01262-UNJ Document 30 Filed 07/12/21 Page 3 of 4
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
MICHAEL POSTLEWAIT,
Petitioner, No. 19-1262V
Chief Special Master Corcoran
v. ECF
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
RESPONDENT’S PROFFER ON AWARD OF COMPENSATION
On August 22, 2019, Michael Postlewait (“petitioner”) filed a petition for compensation
(“Petition”) under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to
34 (“Vaccine Act” or “Act”), as amended. Petitioner alleges that he suffered a Shoulder Injury
Related to Vaccine Administration (“SIRVA”) as a result of an influenza (“flu”) vaccine
administered to him on January 16, 2018. On February 4, 2021, respondent filed his Vaccine
Rule 4(c) report, recommending that compensation be awarded. On February 5, 2021, the Chief
Special Master issued a Ruling on Entitlement finding petitioner entitled to compensation.
I. Items of Compensation
Respondent proffers that petitioner should be awarded $72,500.00 in pain and suffering
damages. See 42 U.S.C. § 300aa-15(a). Petitioner agrees.
II. Form of the Award
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respondent recommends that the compensation provided to petitioner should be made through a
lump sum payment as described below and requests that the Chief Special Master’s decision and

Case 1:19-vv-01262-UNJ Document 30 Filed 07/12/21 Page 4 of 4
the Court’s judgment award the following1: a lump sum payment of $72,500.00, representing
compensation for all elements of economic and noneconomic damages, in the form of a check
payable to petitioner, Michael Postlewait.
III. Summary of Recommended Payments Following Judgment
Lump sum payable to petitioner, Michael Postlewait: $72,500.00
Respectfully submitted,
BRIAN M. BOYNTON
Acting Assistant Attorney General
C. SALVATORE D’ALESSIO
Acting Director
Torts Branch, Civil Division
HEATHER L. PEARLMAN
Acting Deputy Director
Torts Branch, Civil Division
DARRYL R. WISHARD
Assistant Director
Torts Branch, Civil Division
/s/ Julia M. Collison
JULIA M. COLLISON
Trial Attorney
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Ben Franklin Station
Washington, DC 20044-0146
Tel: (202) 305-0102
Julia.collison@usdoj.gov
Dated: May 27, 2021
1 Should petitioner die prior to entry of judgment, the parties reserve the right to move the
Court for appropriate relief. In particular, respondent would oppose any award for future lost
earnings and future pain and suffering.
2